Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial

Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial

Abstract Although continuous erythropoietin receptor activators (CERAs) are widely used erythropoiesis‐stimulating agents for correcting renal anemia in patients undergoing hemodialysis (HD), few reports have examined weekly CERA administration. In this randomized controlled trial, we compared the e...

Full description

Bibliographic Details
Main Authors: Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:The Journal of Clinical Hypertension
Subjects:
continuous erythropoietin receptor activator
erythropoietin‐stimulating agent
iron metabolism
japanese hemodialysis patients
renal anemia
Online Access:https://doi.org/10.1111/jch.14171

Internet

https://doi.org/10.1111/jch.14171

Similar Items